This paper compares the gene expression profiles identified by short (Affymetrix U95AV2) or long (Agilent Hu1A) oligonucleotide arrays on a model for upregulation of a cluster of antioxidant responsive element-driven genes by treatment with tert-butylhydroquinone. MAS5.0, dCHIP, and RMA were applied to normalize the Affymetrix data while Lowess Regression was considered for Agilent data. SAM was used to identify the differential gene expression.
INTRODUCTION
The recent popularity of microarray technology can be attributed to its successful application to a wide range of biological areas including toxicity profiling, drug discovery and screening, clinical diagnosis, and outcome prediction.
This revolutionary technology has brought a new outlook for the study of gene expression networks at the transcriptional level, providing a valuable insight into the molecular mechanisms underlying processes from embryonic development and organ formation, to progression of diseases, and to the effect of drugs. Despite being a relatively new technique, arrays exist in a variety of forms and can be classified based on a number of attributes, including length of target sequence (long cDNAs or oligonucleotides), commercial or custom made, glass or membrane based, and spotted or in situ synthesized [39] . Due to an unprecedented marketing potential predicted in the near future, several major biotech companies have been competitively involved in developing their own patented microarray platforms integrated with their independent data-mining solutions. Incytes's LifeSeq Gold databases, whereas Affymetrix array uses public genomic databases. In a collaborative effort between Agilent and Rosetta Inpharmatics (Kirkland, WA), Agilent launched a new, flexible platform, 60-mer oligonucleotide arrays, which embraces an in situ oligonucleotide synthesis method in which the ink-jet printing process is modified to accommodate delivery of phosphoramidites to directed locations on a glass surface. Using the flexibility offered by this system, Hughes, et al. has characterized the importance of various experimental parameters to hybridization specificity and sensitivity [20] . The company claims that its longer 60-mer probe affords between five and eight times more sensitivity than Affymetrix's 25-mer probes ("Performance comparison of Agilent's 60-mer and 25-mer in situ synthesized oligonucleotide microarrays" in Agilent Internal Report, www.chem.agilent.com).
Affymetrix (Santa Clara
Flexibility in the creation of new arrays is becoming increasingly important as more refinement of the genomic sequences, more knowledge of alternative splicing, and more understanding of the limited cross-validation among different array platforms occurs. Multiple microarray formats for measuring genome-wide gene expression levels are currently available. Increasingly accessible microarray platforms allow the unrestrained and rapid generation of a large volume of expression datasets. Therefore, whether data generated from multiple microarray formats are interchangeable, convertible, and comparative, and how much we can rely on these data is an important issue facing life scientists. In fact, several comparative studies have already been undertaken. However, the results show either high correlation [3, 32, 66] or low correlation [29, 44, 56] between the data generated from different array formats.
There is also a lack of information on the comparative study between widely used, Affymetrix short oligo arrays and recently developed, Agilent long oligo arrays.
To address the concerns of cross platform microarray studies as described above, researchers must select an appropriate experimental model. Toxicologists immediately recognized the impact that the microarray could have on the study of drug toxicity and rapidly embraced this technology as one of the bright futures of toxicological analysis; they termed it toxicogenomics. Transcriptional regulation of multiple detoxification enzymes is one of the major gene clusters focused on by toxicologists.
Examples of detoxification enzymes include NAD(P)H:quinone oxidoreductase (NQO1), epoxide hydrolases, glutathione S-transferases (GSTs), N-acetyltransferases, sulfotransferases, and UDP-glucuronosyltransferases (UGT),
and other enzyme superfamilies [51] . The ability of these enzymes to conjugate redox-cycling chemicals is an important protective mechanism against electrophiles and oxidative stress. The transcriptional activation of the detoxification enzymes and/or antioxidant genes by redox-cycling chemicals has been traced to a cis-acting element called the antioxidant responsive element (ARE) that regulates either or both constitutive and inducible gene expression. ARE sequences have been detected in the promoter region of genes including rat and mouse GST-Ya [6, 16, 53] , rat GST-P [17] , rat and human NQO1 [9, 23] , murine heme oxygenase-1 (HO1) [1, 37] , murine ferritin heavy chain [50] , as well as the murine γ-glutamylcysteine ligase catalytic (GCLC) [12, 48] and regulatory (GCLR) subunits [13, 46] . The mechanisms that regulate phase II detoxification gene expression through ARE activation are under intense investigation. Several ARE-binding proteins have been proposed and/or identified. Nrf2, a member of the "cap 'n' collar" (CNC) basic leucine zipper transcription factor (bZIP) family has been demonstrated to play a central role in gene expression [47] . Using Affymetrix microarrays, we have published multiple datasets related to Nrf2 dependent, ARE activation models, which include tBHQ induced ARE-driven gene expression in a neuroblastoma cell line [40, 41] and primary neuronal culture [33] , Nrf2 dependent ARE-driven gene expression in primary mouse/rat neuronal and astrocytic cultures through adenovirus-mediated Nrf2 overexpression [27, 55] , and 4
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Nrf2 dependent gene expression in mouse liver by comparing Nrf2 knock-out mice to wild-type littermates [42] . Cross comparison of the multiple datasets has allowed us to finally narrow down to 20 potential biological markers which appear to be upregulated by Nrf2-ARE pathway. A majority of them have also been reported by other researchers to be involved in the Nrf2-ARE signaling pathway. Therefore, dissecting tBHQ induced ARE-driven gene expression is a stringent and useful model to evaluate differential gene expression identified by different array formats. In this study we analyzed identical RNA preparations using two commercially available, high-density microarray platforms.
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MATERIALS AND METHODS
Tissue collection and Cell culture
Human fetal cortical tissue (between 8 and 13 weeks post-conception) was collected following routine terminations of pregnancy. All fetal tissue was kindly provided to the laboratory of Dr. Clive Svendsen's laboratory passaged every 14 days by sectioning into 150 µm sections, which then were reseeded into fresh growth medium containing 70% DMEM, 30% Hams F12, 1% penicillin/streptomycin/amphotericin B supplemented with 20 ng/ml EGF, 10 ng/ml LIF and 1% v/v N2 at a density equivalent to 200,000 cells per ml. Half the growth medium was replenished every 4th day [64] .
Cells were treated with vehicle (EtOH, 0.01%) and tBHQ (20µM) for 24h. According to the cell viability assay (MTS) and ARE-luciferase assay, the concentration of tBHQ selected for the following experiment has been proven to induce significant ARE activation with no observable toxicity in this culture model.
Total RNA isolation and quantitative measurement
Human total RNA was isolated using Trizol (Life Technologies). The quality of total RNA and fragmented cRNA was easily visualized on a 2100 Bioanalyzer (Agilent Technologies) using the RNA 6000 LabChip kit. The ratio of 260/280 absorbance was also measured by UV spectrophotometry. Five µg of high-quality total RNA (as shown in Supplemental Figure 1 ) was used as a template for the following cRNA synthesis for both array platforms.
Target preparation and array hybridization
Both in situ synthesized long oligo arrays (Hu 1A) from Agilent Technologies and short oligo arrays (U95Av2) from Affymetrix were used to measure differential gene expression. Some technical parameters related to the array formats are briefly described in Table 1 . Target preparation and array hybridization were conducted according to the manufacturer's protocol. No Change = 0, Marginal Increase/Decrease = 1/-1, and Increase/Decrease = 2/-2. The final rank equaled the sum of the ranks from the three comparisons, and the value varied from -6 to 6 for a three paired-comparison. The coefficient of variation (CV) and Standard Deviation/Mean for the average fold change (FC) were also calculated.
Other normalization approaches also were applied to Affymetrix data. Through close examination of signal intensity from perfect match (PM) and mismatch (MM), several publications reported that MM probes interfere with fold change calculation and also presented cases where genes were mistakenly classified as absent due to high MM signal [26, 35, 67] . Since MM signal may overcorrect PM signal and this may not represent the real MM as hypothesized, PM-only based signal intensity normalization and calculation have been recommended.
The analysis methods considered in this paper include: (1) Algorithms built around an intensity-modeling approach implemented in dChip v1.3 (www.dchip.org) [36] and (2) expression values also were calculated using the Robust Multiple Average (RMA) method [4, 21] . Normalization was done using quantile normalization. Software for RMA is available for download at www.bioconductor.org for use in the R-package for statistical computing (www.rproject.org).
For the Agilent arrays, the default settings of the Agilent G2566AA Feature Extraction Software were used, which selects the LOWESS (locally weighted linear regression curve fit) normalization method after local background subtraction ("Robust local normalization of gene expression microarray data" in Agilent Internal Report, www.chem.agilent.com). Specifically, it performs a large number of local regressions in overlapping windows along the length of the data and then joins the regressions together to form a smooth curve. Lowess regression has been shown to significantly eliminate systematic bias contributed by dual-dye labeling systems. It is a within-array normalization, not the same as dCHIP or RMA. Data flagged as having poor quality by the Agilent extraction software were removed from the analysis. Output from the Genechip analysis was merged with the Unigene or GenBank descriptor and stored as an Excel data spreadsheet.
MvA plot
Normalized data were visually displayed by plotting a signal log ratio (M) versus the average log intensity (A), namely, MvA plot.
Cross-Platform Comparisons of Expression Data
Each microarray platform reported the GenBank ID of the sequence interrogated by each of the probes or probe sets on the array. These GenBank IDs were then converted to their corresponding UniGene ID. RESOURCERER, developed by The Institute for Genomic Research (TIGR), is a high-throughput web-based database for the annotation and comparison of commonly available microarray resources. It allows comparisons between resources from the same species using either the TIGR Gene Indices or UniGene, and between species using the TIGR EGO database (pga.tigr.org). The relationships between expression measurements made with different array types were assessed by
Pearson's correlation coefficient.
Detection of differential gene expression
Tusher, et al, recently proposed a similar permutation based algorithm called Significance analysis of microarrays (SAM), addressing this same problem by controlling the false discovery rate (FDR) of differential gene lists [58] .
SAM uses an algorithm based on the Student t test and also performs data permutations to determine the FDR. The
Software is free for download at www.stat.stanford.edu/~tibs/SAM.
Data Deposition
Raw data from this study are available from GEO (http://www.ncbi.nlm.nih.gov/geo) and are listed under the following accession numbers: GSE768 (for the entire experimental series), GSE759 (for the neural stem cells), GSE761 (for the neuroblastoma cells), and GPL91 (for Affymetrix U95Av2 arrays), GPL553 (for Agilent Hu1A arrays).
Real-time RT-PCR
Total RNA used for microarray analysis also was applied for quantitative RT-PCR. Double-strand cDNA was produced from 4 µg of each RNA sample using an Ambion reverse transcriptase catalyzed, T7 oligo dT primer (MessageAmp aRNA kit, Ambion). The cDNAs used for real-time PCR were not the same for two microarray 8 Data was presented as mean ± SE (n=3) of the ratio between the concentrations of a specific template from vehicle and tBHQ -treated samples. A one-tail, paired t-test was also performed on the concentrations between tBHQ and vehicle treated groups, and p<0.05 was considered as the significant gene expression changes.
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Both in situ synthesized long oligo arrays (Hu 1A, Agilent Technologies) and short oligo arrays (U95Av2, Affymetrix) were used to measure differential gene expression in RNA samples generated from human neural stem cells (CTX066) treated with vehicle (EtOH, 0.01%) and tBHQ (20µM) for 24h. The same RNA samples were used for the comparison study. Three arrays per condition were used for each platform. The samples were harvested in three different cell passages instead of pooling samples or repeating the same sample. Provided that the sample labeling of mRNA was carried out separately from different extractions, this approach led us as close to independent experimental results as was feasible in this context [7, 65] . According to RESOURCERER 6.0, there were approximately 9556
UniGene clusters that were represented in both Affymetrix U95Av2 array (~12, 000 clones and/or ESTs) and Agilent Hu 1A array (~17,000 clones and/or ESTs). Therefore comparisons were limited to the 9556 unique clusters.
Data Normalization
We assembled a list of 20 candidate genes based on the multiple datasets generated in our lab ( Table 2 ). All these genes had been previously implicated in the tBHQ-induced ARE activation pathway. Since these genes also were individually described as upregulated by tBHQ and/or through the Nrf2-ARE pathway, our main focus in this study was on transcriptional upregulation related gene expression profiles. We also monitored 23 housekeeping genes whose gene expression level remained constant. These are classified as cytoskeletal proteins, ribosomal proteins, or metabolic enzymes and have previously been used as controls in several publications (Supplemental Table 2 ) [8, 34, 59 ].
Multiple statistic model-based data normalization approaches have been proposed for Affymetrix platform [53].
However, a gold standard method has not been defined yet. Thus, method selection should be motivated by the application at hand and the goals of the data analysis.
As shown in Figure 1 , when compared with other normalization approaches, MAS 5.0 analysis of both intergroup and intragroup pairings has the largest variations observed across the whole data set except for that of RMA intergroup analysis. This is extremely obvious in the scatterplots which form a so called "funnel shape" at low signal intensities.
Here, the relationship between control and treatment groups was regarded as an intragroup relationship, while the three biological replicates was considered an intergroup relationship. The dCHIP model produced a better intergroup or intragroup correlation with respect to the MAS scaling procedure as shown in Figure 1B . Figure 1C illustrates the good data distribution from intra C groups or intra T groups after quantile normalization by RMA. However, scatter plots for intergroups demonstrated a huge data variation across the whole spectrum of signal intensity values. This indicates that there were no correlations between controls and treatments.
As shown in Figure 1E by one tailed, paired, t-test on Pearson's correlation coefficient (R 2 ), the averaged r 2 from the intra-control group (0.693; 0.852) and intra-treatment group (0.669; 0.810) from MAS5.0 and dCHIP(PM-only) are very close to each other (P>0.05), indicating that these two procedures did not affect the global similarity between samples. dCHIP(PM-only) provided a higher correlation compared to dCHIP(PMMM) in terms of intra-group correlations and gave a better fit than MAS5.0 scaling in terms of inter-or intra-group correlation. The quantile normalization from RMA significantly increased the intra-group correlation (C, 0.913; T, 0.896), and also dropped the intergroup correlation (0.067) dramatically, implying that this approach amplified the difference between the control and treatment groups but decreased the variation (bias) generated from biological replicates. Therefore, RMA seems to be a more effective way than MAS5.0 or dCHIP(PM-only) to normalize the Affymetrix data in terms of biostatistical significance between control and treatment groups.
One representative set of pair-matched comparison data was MvA plotted as show in Figure 2 using multiple data normalization tools. Through comparing the MvA plot generated by MAS 5.0, dCHIP, and RMA normalized raw Affymetrix data, the low average log intensity data had greater variation in the MAS 5.0 generated MvA plot. The tightness of a MvA plot generated after dChip(PM-only) or RMA normalization only suggests that the low level background noise is consistent, not that probe data in that range is accurate or sensitive for measuring changes between arrays. Data that has been normalized represents data that has been modified to reduce error based on different statistical hypothesis and algorithms. It may or may not represent the biological relevance of the datasets. Therefore, we highlighted 20 known differentially expressed genes and 23 consistently expressed housekeeping genes (described in Supplemental Table 2 ). in the MvA plots. The biological markers selected here covered genes with low basal intensity (HO1, NQO1) to those with high basal intensity (GCLR, Ferritin). The average signal intensity for most of the housekeeping genes is relatively high.
All of the three MvA plots from MAS 5.0 (Figure 2A ), dCHIP ( Figure 2B ), and RMA ( Figure 2C ) showed a similar distribution pattern for the selected markers. Most biological markers were far above the baseline cloud formed by the majority of unchanged genes, while the housekeeping genes tightly resided in this regions. These data indicate that although dCHIP and RMA showed tighter scatter plots across the dataset than MAS 5.0 did, it was difficult to draw a conclusion on which normalization approach was better from a biological point of view.
For the Agilent array system, the most commonly used normalization method is called Loess (Lowess) regression. Figure 1D and 2D show the performance of this Lowess normalization on Agilent data. Correlations amongst the interand intra-groups were similar to that of dCHIP or RMA (intra group only). MvA scatter plots showed Lowess regression analysis provided a nice plot across the whole span of the average intensity values.
SAM on differential expression identification
Since we had established a set of biological markers and housekeeping genes, we interrogated SAM on how many biological markers could be identified as significant positives and how many housekeeping genes could be excluded as significant positives. Before doing this, we needed to estimate the magnitude of gene expression in the tBHQ-induced, ARE activation model. Assuming 500 genes or 1000 genes showed differential gene expression, how many significant positives could we get from the SAM after different normalization approaches, and how much was the corresponding false discovery rate? Figure 3 summarizes the results from SAM analysis. There were similar numbers of positive genes identified by RMA-SAM (158), MAS 5.0 (122). Interestingly, only 17 positive genes could be identified by dCHIP-SAM. However, the majority of them were the biological markers or had significant biological relevance.
When comparing the different array formats, it was noted that Agilent arrays identified most of the biological markers to the final report. Hence we believe the RMA-SAM strategy was not an appropriate way to identify the differential gene expression. Although the dCHIP-SAM plot showed a very rigid curve and the number of differential genes expressed did not correlate with the change of the ∆ value, it did identify 50 % of the biological markers within 17 discovered positive genes. We proposed that dCHIP-SAM might help the researcher get a panel of true biological markers in unknown biological models. However, false negatives could not be neglected due to the data normalization.
Receiver Operator Characteristic (ROC) curves provide a graphical representation of the tradeoff between sensitivity and specificity. In signal detection theory, a ROC is created by plotting the true positive (TP) rate (sensitivity) against false positive (FP) rate (1-specificity) obtained as the discrimination threshold is varied. Proposed numbers of differential gene expression changes were considered as the dynamic threshold. We ranked the genes based upon the absolute score generated by SAM. Since the 20 biological markers were actually differentially expressed in these experiments and the 23 housekeeping genes were considered unchanged across the treatments, it was easy to determine the TP rate (the number of biological markers identified/20) and FP rate (the number of housekeeping genes misidentified/23). The best possible prediction method would yield a graph that had data-point in the upper left corner of the ROC space. The closer the curve followed the left-hand border and then the top border of the ROC space, the more accurate the test. The closer the curve came to the 45-degree diagonal of the ROC space, the less accurate the test. Hence, in terms of Affymetrix data, RMA gave the worst prediction while MAS5 and dCHIP(PM) showed similar accuracy, which was slightly better than dCHIP(PMMM). Agilent-SAM also provided better prediction than RMA-SAM, but not as good as MAS5-SAM or dCHIP-SAM.
Finally, we chose MAS5-SAM and Agilent-SAM approaches to observe how many overlapping genes were present. In this study, two levels of estimation were set up based on the dynamic change of the ∆ value or FDR value.
If the multitude of the differential gene expression were set to around 475, 16.0 % of genes were identified by both array formats, however only 8 genes overlapped. If we assumed 920, around 15.8 % genes were on the both arrays, just 22 genes were overlapping. These data suggest that only a limited number of gene expression profiles have been captured by both Affymetrix and Agilent arrays and that each format generated their own gene list.
Exemplifying the cause of discrepant data generated by Affmetrix and Agilent arrays.
We have analyzed the gene expression changes by qRT-PCR from a total of 25 genes that increased in both platforms or one and not the other. We noticed that the introduced biological markers were mostly confirmed by qRT-PCR as shown in Table 3 , and some new markers revealed by both array systems were also verified, which includes ATF3, Asparagine synthetase, GEMGTPase and Uridine phosphorylase. As one of the potential Nrf2 binding partners, ATF3 has been shown to be involved in Nrf2 dependent ARE activation [15] . Asparagine synthase, which catalyzes ATP-dependent conversion of aspartate to asparagine using an amine group from glutamine or ammonia, expression is induced upon amino acid and glucose deprivation and induction increases cancer cell resistance to chemotherapy.
GEMGTPase, a gene expressed in mitogen-stimulated cells, binds GTP, calmodulin, microtubules, and the kinesinlike protein KIF9, may be involved in cell shape control, neuron differentiation and calcium channel regulation.
Uridine phosphorylase is involved in nucleoside metabolism. Therefore, integration of the gene expression data generated from both array systems may quickly narrow down to 22 markers which can be cross-validated with strong biological relevance. Although the number is limited, it does give us a high confidence to further interrogate whether the gene expression changes identified by the alternative approach are real and can be verified by qRT-PCR. The issues related to alternative splicing, site of probe construction, probe set vs. single measurements, and use or non use of mismatch probes have been proposed to be responsible for the discrepant data.
Alternative splicing
Alternative splicing is proposed to account for the genetic complexity in mammalian transcriptomes. In human, approximately 60% of genes undergo alternative splicing [31, 61] . The flavin-containing monooxygenases (FMOs) are a family of enzymes that catalyze the oxygenation of numerous nitrogen-, sulfur-, phosphorous-and other nucleophilic heteroatom-containing chemicals and xenobiotics [5, 68] .
FMOs show overlapping substrate specificity among the six family members. All FMOs are the result of alternative splicing. The boundaries and sizes of these coding exons are highly conserved among family members and across animal species. Expression of FMOs is tissue-and species-dependent [18] . For example, FMO3 is the most abundant isoform in adult human liver [43] , whereas in adult human kidney and fetal human brain, FMO1 is the most prominent form [10] . Transcriptional regulation of FMOs expression has not been well characterized. A recent report through genetic comparisons of the gene expression of detoxification enzymes in Nrf2 knock-out versus wild-type mice by Affymetrix arrays showed that there was a significant decrease in FMO (Consensus sequence) and FMO3 in liver samples from knock-out mice [42] . Since tBHQ was proved to stabilize Nrf2 by inhibition of the ubiquitin-proteasome pathway (Li, et al . unpublished data), we proposed that FMO could be a potential Nrf2-driven gene. In the present study, the data generated from Affymetrix array showed a substantial increase in FMO1 instead of other FMOs after human neural stem cells were treated with tBHQ for 24h. The gene expression change for FMO1were confirmed by qRT-PCR using a sequence-specific set of primers for the unique 3'UTR (Blast search confirmed). Actually, adenovirus-mediated overexpression of Nrf2 increased FMO1 at the mRNA level (data not shown). However, the data generated from Agilent array showed no changes in FMO1expression. Through comparing the locations of probe(s)
selected by both array formats, we found that Affymetrix probesets not just covered the exon 9, but also the unique 3'UTR region for FMO1 ( Figure 5A1) ; whereas the Agilent probe for FMO1 only covered 60 bp in exon 9, which also was shared by FMO4 (Blast search confirmed). A 20 bp sequence from this 60 mer probe demonstrated a 100% homologue with Jagged 2, which is highly expressed in neural stem cells. In many cases, in terms of specificity, the probe was designed within the 3' UTRs because they share less homology with each other than is the case with the coding regions between genes ("The Design and Annotation of the Applied Biosystems Human Genome Survey
Microarray", doc.appliedbiosystems.com). Only the probes covering the 3'UTR region showed a dramatic difference in fluorescence intensity between vehicle and tBHQ treated samples as shown in Figure 5A2 . One set of primers, specifically designed for the 3'UTR showed significant changes by qRT-PCR (Table 3) suggesting that in some cases, multiple probes have advantages over a single probe in detecting alternative splicing. In addition, according to the basis of thermodynamics and kinetics of nucleotide hybridization here, precision and accuracy are affected when oligonucleotide hybridizations are not long enough to reach probe/target on-off equilibrium.
Multiple probes vs. single probes
As we described earlier, multiple probes may have advantages over single probes in identifying alternative splice variants. If there is a certain level of RNA degradation, cross-hybridization, and/or poor hybridization just occurs in the region from which the sole probe was selected, the result will be skewed. Therefore, using results from multiple probes would provide an overall effect sometimes better than single probes in determining the gene expression changes if the single probe may not behave well enough to represent the interrogated gene. For example, RNA polymerase III subunit 32, an abundant subunit of RNA polymerase III, and part of a subcomplex important for the initiation of transcription, was identified as an upregulated gene by Affymetrix array and this upregulation was confirmed by qRT-PCR using a set of primers specifically targeting the coding region. However, the single probe selected by Agilent array is not able to identify this change. The probe construction sites for both arrays were aligned with the full cDNA sequence as showed in Figure 5B1 . Although Agilent claimed that their probes were selected from 3' end of the sequence, this one was an exception. Given that poor hybridization, RNA degradation from 5' and/or less labeling efficiency (RT-IVT labeling has a higher efficiency in incorporating labels into cRNA and cDNA in 3'end than 5' end.) occurred in that region, there is no way to identify the changes based upon this single probe. Actually, the Figure 5B2 showed the fluorescence intensity of PM and MM for each probe of RNA polymerase III.
Another example comes from a well-characterized Nrf2-driven, stress-response gene, sequestosome 1, also called A170 in mice. Electrophilic agents, such as diethylmaleate and tBHQ, were reported to induce the gene expression of sequestosome 1 [22] . As shown in the Affymetrix probeset, 13 of 16 probes representing this gene showed a dramatic difference ( Figure 5C2 ). However, Agilent probes showed no change with extremely high fluorescence intensity in vehicles, and 2273.6, 1473.6, and 2744.5 for treatments). These data suggest that cross-hybridization perhaps occurred when selecting probe(s) from this region. QRT-PCR using the primers specific to the coding region confirmed the increased gene expression of sequestosome 1 after tBHQ treatment (Table 3) . Once again, the site of probe construction is important in determining gene expression level and the assessment of hybridization behavior from multiple probes does provide more comprehensive data than single probe in some cases.
TR1 is a good example for the multiple-probe approach. As shown in Figure 6A , 15 out of 16 probes showed the same trend except for probe # 4 when comparing the levels between vehicle and treatment groups. However, in many cases, the 16 probes within a probeset did not perform similarly. For instance, upregulation of NPTX1, a neuronalspecific protein involved in synaptic uptake of extracellular material in response to xenobiotic-induced toxicity, was identified only by the Agilent array and confirmed by qRT-PCR (Table 3) . Through an analysis of the hybridization performance of the 16 probes, we found that there were many (10/16) bad probes including 2, 3 (high mismatch), 5, 7-11, 15,16 (high mismatch) selected to represent NPTX1 ( Figure 5D2 ). After integration of the results from all the 16 probes, the real difference, reflected by probe # 1, 4, 6, 12-14, was disguised suggesting the site of probe construction is crucial to determine the gene expression changes. Actually, the sequences for probe # 12-15 matching with the single probe from Agilent showed similar results implying that there was increased expression of NPTX1 after tBHQ treatment ( Figure 5D1) . Thus, this region should only be considered as a site for probe construction.
Use or non-use of mismatch probes
In some cases, a single mutation may not substantially influence the hybridization efficiency. Introducing two or more mutations may start to substantially change the hybridization behavior. Therefore, to incorporate mismatch probes with single mutation in the middle of probes may not well-represent cross-hybridization or background signal as thought by Affymetrix MAS5.0. Carbonyl reductase 1 (CR1), a detoxfication enzyme, is an example. CR1 is a broad-specificity NADPH-dependent oxidoreductase that catalyzes the reduction of aromatic ketones, quinones, prostaglandins, and ketone-containing drugs; decreased expression may correlate with reduced survival in certain cancers. CR1 is also regulated through the Nrf2-ARE pathway [30, 57] . Data from Affymetrix arrays always showed no changes based on the detection call from MAS5.0 or significance testing by SAM. As shown in Figure 6B , the According to our results, the reproducibility of data was highly dependent upon the data normalization approaches used. As shown in Figure 1E , dCHIP (PM-only) normalized Affymetrix data showed the highest intergroup reproducibility that was similar to LOWESS normalized.. Agilent data. However, in terms of intragroup reproducibility, RMA showed the highest reproducibility, even higher than Agilent data (P<0.05). Intragroup data generated from MAS5.0 showed less reproducibility than DCHIP, RMA, and Agilent data. However, less reproducibility is not always equivalent to less accuracy. RMA provided a higher intergroup correlation coefficient than dCHIP and MAS5.0 scaling while significantly decreasing the intragroup correlation. However, RMA-SAM analysis resulted in a large number of false positives to the final report. A recent paper tried to explain why RMA works better in some microarray experiments like spike-in samples while generating so many false-positives in others
[54]. The increased sensitivity of probe set algorithms that ignore the mismatch signal, such as RMA would be expected to come at an increased cost of noise, where the quality of low level signals defined by RMA were "noisy"
projects which could lead to data interpretations of poor integrity. Specifically, detection of spike-in controls would be expected to be independent of confounding noise within arrays and projects. However, the increased sensitivity of some probe set algorithms would be expected to lead to a high proportion of false positives in projects where there was relatively high level of unwanted noise.
Further analysis of the data revealed by alternative approaches suggested that alternative splicing, multiple vs. single probe(s) measurement, and use or nonuse of mismatch probes may account for the discrepant data. Other factors resulting in the discrepant data may include probes selected from the wrong or partially accurate cDNA sequence.
Jarvinen, et al. compared microarray data generated from Affymetrix U95Av2 and Agilent cDNA array and found that more than half of the discrepant cases that they investigated could be explained by the incorrect clones after sequencing [24] . However, when comparing the sequence matched probes from these two platforms, Mehcam, et al.
showed significantly improved cross-platform consistency in terms of gene expression ratios and different calls [45].
Although we exemplified several issues perhaps related to the discrepancy derived from Affymetrix and Agilent arrays, it is possible that multiple factors may simultaneously be responsible for the discrepancy.
Based upon this study, the data interchangeability across different microarray formats is limited. However, through cross-platform comparisons, researchers could validate positive genes generated from different formats and quickly narrow down the real biological markers in unknown biological models. For this reason, both Affymetrix [14] and Agilent [60] platforms provided very successful examples of clinical diagnosis and outcome prediction. Through combination with clustering analysis, those finally settled biomarkers could classify an unknown sample into different categories [49] . In this case, the variation in gene discovery across different microarray platforms seems not to be a big issue. Unfortunately, for most of array-based, initial global screening experiments, missing the important messages could result in incomplete or incorrect conclusions. By merging the datasets, the investigator may generate a more sophisticated gene expression pattern and provide a wide view of transcriptional networks. This combination will not be realized as a better option for presenting and analyzing microarray data until more cross-platform studies have been carried out and reported using performance figures with predictive algorithms such as the logistic regression and discriminate function analyses.
Although the methodologies described in this study are the most widely used, we should realize that none of them were the "gold standard". Microarray Bioinformatics is a booming area and many new solutions are constantly appearing and being updated. The next generation of strategies for microarray data analysis should be a combination of multiple data normalization approaches with various significance testings. Multiple formats of microarray technology will exist for years and the microarray industry will experience continuous reconstruction. Just like computer formats (PC or MAC), no single array format could constantly dominate the market. Improvement on the existing microarray formats on multiple levels may be more urgent than simply trying to make a bigger array covering 19
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more uncertified genes. A number of factors, including variabilities generated from multiple steps of microarray technology often lead to results that fail validation by other techniques such as qRT-PCR. The multiple levels we refer to include probes (probesets) selection, quality controls, and industrial standards for array manufacture, general limits of fluorescent microarray technology, dye bias, data deposition and data mining tools. We hope that the data generated from microarray technology will become more accurate in the future. Currently, RNA standards are being developed and hopefully may help us identify probes which are inaccurate ("External RNA controls for monitoring performance of Codelink whole genome bioarrays" in Amersham application note, www.amershambiosciences.com). With these standards, researchers will be able to create algorithms that precisely identify the conversion constants that will convert intensity value directly to mRNA copy number. Until that time, we must understand the limitations of the systems used and realize that we may be catching only a few fish out the school with the hope that these few fish will be key indicators for the overall function of the school.
It should also be noted that both Affymetix and Agilent are continually updating and refining their array designs and future experiments on newer arrays may also yield some different results. Hence, researchers who are interested in a particular field are encouraged to have custom designs of either array format. A stronger conclusion on crossplatform performance will be made based on those custom arrays. One-tailed, pair match t-test was performed. The high quality RNA electropherogram showed several characteristics. First, there were clear 28S and 18S peaks were present. Furthermore, there was low noise between the peaks and minimal low molecular weight contamination.
RNA Ratio [28S/18S] was greater than 1.90. Spectrophotometrically the RNA showed that the A 260nm /A 280nm ratio was around 2.0 (>1.9). We also applied this technology to fragmented cRNA. To avoid secondary structure formation, which might hinder targets from reaching the probes in high-density microarrays and to increase the hybridization efficiency based on the thermodynamic theory, complete fragmentation of cRNA (50-100bp) should be achieved prior to the hybridization process. As shown in Figure 1B , a clean, sharp, low molecular weight band was observed in the cRNA electropherogram, representing complete fragmentation of the cRNA. Table 1 come from Agilent or Affymetrix's internal report and product datasheet (Agilent Hu 1A, see to http://www.chem.agilent.com/Scripts/PDS.asp?lPage=7303; Affymetrix U95Av2, see to http://www.affymetrix.com/products/arrays/specific/hgu95.affx). Some of the comparisons including "Time for sample preparation and hybridization and washing" were based upon the author's work experience. * represents the change of gene expression identified by microarray analysis is confirmed by RT-PCR. = The statistics (bitscore and expect value) are calculated based on the size of nr database. "No Sig" represents no significant homology between the two sequences through BLAST2 (http://www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html).
Housekeeping Gene b actin 0.985± 0.149 Data was presented as the ratio of the concentrations between tBHQ and Vehicle treated samples for a specific template. * represents the significant gene expression change , p<0.001, based upon one-tail, paired t-test of the concentrations between tBHQ and vehicle treated groups.
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